Indirect comparison of efficacy of dupilumab versus mepolizumab and omalizumab for severe type 2 asthma

Katrine Praetorius; Daniel P. Henriksen; Johannes M. Schmid; Pernille Printzlau; Lars Pedersen; Hanne Madsen; Ehm A. Andersson; Louise Klokker Madsen; Bo L. Chawes

doi:10.1183/23120541.00306-2021

Indirect comparison of efficacy of dupilumab versus mepolizumab and omalizumab for severe type 2 asthma

Katrine Praetorius, Daniel P. Henriksen, Johannes M. Schmid, Pernille Printzlau, Lars Pedersen, Hanne Madsen, Ehm A. Andersson, Louise Klokker Madsen, Bo L. Chawes^*

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Leder › Forskning › peer review

9 Citationer (Scopus)

8 Downloads (Pure)

Originalsprog	Engelsk
Artikelnummer	00306-2021
Tidsskrift	ERJ Open Research
Vol/bind	7
Udgave nummer	3
Antal sider	5
ISSN	2312-0541
DOI	https://doi.org/10.1183/23120541.00306-2021
Status	Udgivet - 2021

Adgang til dokumentet

10.1183/23120541.00306-2021Licens: CC BY-NC

FulltextForlagets udgivne version, 280 KBLicens: CC BY-NC

Citationsformater

@article{4cce2cc759cc4ad4a20a5be61556b24d,

title = "Indirect comparison of efficacy of dupilumab versus mepolizumab and omalizumab for severe type 2 asthma",

keywords = "QUALITY-OF-LIFE, ADD-ON THERAPY, ANTIIMMUNOGLOBULIN-E THERAPY, SEVERE ALLERGIC-ASTHMA, LONG-TERM CONTROL, DOUBLE-BLIND, ANTIBODY OMALIZUMAB, PERSISTENT ASTHMA, MODERATE, MULTICENTER",

author = "Katrine Praetorius and Henriksen, {Daniel P.} and Schmid, {Johannes M.} and Pernille Printzlau and Lars Pedersen and Hanne Madsen and Andersson, {Ehm A.} and Madsen, {Louise Klokker} and Chawes, {Bo L.}",

year = "2021",

doi = "10.1183/23120541.00306-2021",

language = "English",

volume = "7",

journal = "ERJ Open Research",

issn = "2312-0541",

publisher = "ERS publications",

number = "3",

}

TY - JOUR

T1 - Indirect comparison of efficacy of dupilumab versus mepolizumab and omalizumab for severe type 2 asthma

AU - Praetorius, Katrine

AU - Henriksen, Daniel P.

AU - Schmid, Johannes M.

AU - Printzlau, Pernille

AU - Pedersen, Lars

AU - Madsen, Hanne

AU - Andersson, Ehm A.

AU - Madsen, Louise Klokker

AU - Chawes, Bo L.

PY - 2021

Y1 - 2021

KW - QUALITY-OF-LIFE

KW - ADD-ON THERAPY

KW - ANTIIMMUNOGLOBULIN-E THERAPY

KW - SEVERE ALLERGIC-ASTHMA

KW - LONG-TERM CONTROL

KW - DOUBLE-BLIND

KW - ANTIBODY OMALIZUMAB

KW - PERSISTENT ASTHMA

KW - MODERATE

KW - MULTICENTER

U2 - 10.1183/23120541.00306-2021

DO - 10.1183/23120541.00306-2021

M3 - Editorial

C2 - 34476242

SN - 2312-0541

VL - 7

JO - ERJ Open Research

JF - ERJ Open Research

IS - 3

M1 - 00306-2021

ER -